CommonHealth launches new agency

Share this article:
CommonHealth has formed a new unit called, Altum, a freestanding, professional healthcare advertising and promotion company differentiated by a specialized creative and scientific approach.
Altum is the thirteenth business unit of CommonHealth and the organization's fifth professional advertising agency. The group was formed around a core team of professionals from Ferguson, CommonHealth's founding professional advertising and promotion unit. Michael Parisi will oversee the day-to-day operations of the new venture as executive vice president, general manager. The new organization will report to David Chapman, president of Ferguson.
CommonHealth said in a statement, "Established to respond to marketplace demand for greater focus, flexibility and accountability, Altum was created with the concept of "depth" as part of its unique approach."
"It's great to see such hardworking, dedicated and creative people get their chance to grow and manage an agency of their own. Giving some of our best and brightest the opportunity to focus on the brands and categories they feel most passionate about has been a key factor in the success of our other 'home-grown' companies," said Chapman.
Altum is the seventh CommonHealth company to organically spin off from the organization's Ferguson agency.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.